What about us? Recent advances in the treatment of chronic hepatitis C threaten to leave some parts of the world behind.

J Viral Hepat. 2013 May;20(5):367-8.

Ahmed F.

Division of Gastroenterology, The Aga Khan University, Karachi 75350, Pakistan. furqaan@hotmail.com

Abstract

Directly acting antiviral (DAA) agents are currently revolutionizing the treatment of chronic hepatitis C infection. The first generation of these agents have significant limitations including cost issues that are of particular concern in the developing world and a lack of efficacy in genotype 3 patients. Both of these concerns are of particular relevance in Pakistan. © 2012 Blackwell Publishing Ltd.

PMID: 23565620

Multiselect Ultimate Query Plugin by InoPlugs Web Design Vienna | Webdesign Wien and Juwelier SchönmannMultiselect Ultimate Query Plugin by InoPlugs Web Design Vienna | Webdesign Wien and Juwelier Schönmann